Endoscopy is a minimally invasive procedure with wide usage in diagnostic and therapeutic areas for pulmonology and gastroenterology conditions. Stenosis of the gastrointestinal and airway tracts is a common phenomenon caused by various reasons such as growth of benign tissue, pressure exerted by peripheral organs, symptomatic stenosis of other associated diseases such as Crohn’s disease, and inflammation and abnormal contraction of lumen muscles. Prior to evolution of endoscopic dilation techniques, physicians and surgeons used to opt for surgical interventions to dilate the stricture. Endoscopic dilation is performed by using tools such as plastic dilators, stents, dilating catheters, and balloon dilators. Plastic dilators, also known as Bougie dilators, are more rigid and traumatic. This may cause perforation of the gut wall. Temporary stenting of the stricture tract is also preferred by all surgeons. However, it is an expensive process and it requires repetition of endoscopy to remove the stent in case of benign stricture. With controlled expansion of the balloon, balloon dilators offer ease of use and safety.
Endoscopic balloon dilators are offered as single-use medical devices. The balloon dilation procedure is performed under endoscopic and fluoroscopic image guidance. The balloon is inflated with water, saline, or other liquid materials. Contrast medium is sometimes used to monitor the placement of the balloon and dilation procedure under fluoroscopic (X-Ray) image. Technological advancements in endoscopy balloon dilators have led to availability of balloon dilators of different designs, sizes, lengths, and uses. According to various independent studies, the rate of incidence of achalasia is found to be doubled from 0.8/100000 per year in the 1980s to 1.6/100000 per year post 2000. Changing dietary habits and increasing incidence of chronic diseases are likely to drive the endoscopic balloon dilators market in the near future. However, factors such as short-term dilation and requirement for repetitive procedures are likely to restrict the endoscopic balloon dilators market during the forecast period. Moreover, development of alternative, endoscopic, interventional procedures such as Per Oral Endoscopic Myotomy (POEM) and biodegradable stents is anticipated to hamper the market in the next few years.
The global endoscopic balloon dilators market can be segmented based on application, end-user, and region. In terms of application, the market has been divided into pulmonology and gastrointestinal. The gastrointestinal endoscopic balloon dilators segment has been sub-classified into gastroesophageal dilators, pancreatic–biliary dilators, and achalasia dilators. Increasing prevalence of various gastrointestinal stenosis conditions is estimated to result in leading share held by the gastrointestinal segment. Based on end-user, the endoscopic balloon dilators market has been segmented into hospitals, ambulatory surgical centers, and others. Increasing adoption of minimally invasive procedures such as endoscopy in ambulatory surgical centers is estimated to propel the global endoscopic balloon dilators market from 2017 to 2025.
Geographically, the global endoscopic balloon dilators market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is estimated to hold a leading share of the global market during the forecast period, due to high adoption of endoscopic techniques and high health care expenditure in the region. Europe is estimated to account for a significant share of the global market for endoscopic balloon dilators during the forecast period. Increasing awareness about gastrointestinal and pulmonary stenosis and developing health care infrastructure in emerging markets such as China and India are projected to be responsible for significant growth of the endoscopic balloon dilators market in Asia Pacific during the forecast period.
Major players operating in the global endoscopic balloon dilators market are Boston Scientific Corporation, Olympus Medical Corporation, Merit Medical Endotek, Cook Medical, CONMED Corporation, HOBBS MEDICAL INC., Medi-Globe GmbH, and PanMed US.
This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.
Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:
- Customer Experience Maps
- Insights and Tools based on data-driven research
- Actionable Results to meet all the business priorities
- Strategic Frameworks to boost the growth journey
The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.
The following regional segments are covered comprehensively:
- North America
- Asia Pacific
- Latin America
- The Middle East and Africa
The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.
Below is a snapshot of these quadrants.
1. Customer Experience Map
The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.
2. Insights and Tools
The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.
3. Actionable Results
The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.
4. Strategic Frameworks
The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
1. What can be the best investment choices for venturing into new product and service lines?
2. What value propositions should businesses aim at while making new research and development funding?
3. Which regulations will be most helpful for stakeholders to boost their supply chain network?
4. Which regions might see the demand maturing in certain segments in near future?
5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
7. Which government regulations might challenge the status of key regional markets?
8. How will the emerging political and economic scenario affect opportunities in key growth areas?
9. What are some of the value-grab opportunities in various segments?
10. What will be the barrier to entry for new players in the market?
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.